CTOs on the Move

Epocrates

www.epocrates.com

 
Epocrates, Inc. is a provider of clinical information and decision support tools to healthcare professionals, as well as interactive information services to the healthcare industry. As of April 17, 2008, the Company has subscriber base of over 500,000
  • Number of Employees: 250-1000
  • Annual Revenue: > $1 Billion
  • www.epocrates.com
  • 311 Arsenal Street Watertown
    San Mateo, MA USA 02472
  • Phone: 888.807.2076

Executives

Name Title Contact Details

Similar Companies

Little Rapids

Little Rapids Corporation is a leading manufacturer and marketer of products to the healthcare and beauty markets. Our products promote safety and sanitation, and offer convenience and comfort for professionals and their patients and clients.

Sroufe Healthcare Products

Sroufe Healthcare Products, LLC is a leading manufacturer and worldwide supplier of cast boots, post-op shoes, orthopedic softgoods and accessories. Founded in 1975, Sroufe pioneered the use of lean and cell manufacturing techniques to establish an

Advanced Ultrasound Electronics

Advanced Ultrasound Electronics is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Associated X-ray Services Inc

Associated X-ray Services Inc is a South Bend, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Seno Medical Instruments

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno`s Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that the Imagio OA breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.